论文部分内容阅读
Novartis announced on November 3rd a US$ 1billion investment over the next five years,increasing R & D activities in China and confirmingNovartis’ long term commitment toChina’s further economic development, healthreform and improving the health care of theChinese people. The Novartis investment willinclude a significant expansion of TheNovartis Institute of BioMedical Research(CNIBR) in Shanghai.Demand for healthcare in China is growingrapidly. In addition, the burden of disease now
Novartis announced on November 3rd a US $ 1billion investment over the next five years, increasing R & D activities in China and confirming Novartis’ long term commitment to China’s further economic development, healthreform and improving the health care of the Chinese people. The Novartis investment willinclude a significant expansion of The Novartis Institute of BioMedical Research (CNIBR) in Shanghai. Command for healthcare in China is growingrapidly. In addition, the burden of disease now